Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: To estimate the progression free survival for subjects treated with panitumumab in combination with a chemotherapy regimen of oxaliplatin, 5-Fluorouracil (5-FU) and leucovorin (FOLFOX) as first-line chemotherapy regimen for subjects with metastatic colorectal cancer with WT (wild type) KRAS according to the IGFRp (protein receptor insulin growth factor) and MMP-7 (Matrilysin) expression.
DISEASE(S): Metastatic Colorectal Cancer,Pacientes Con Cáncer Colorrectal Metastásico Y Tumor Con Kras No Mutado Tratados Con Folfox6m Y Panitumumab Como Tratamiento De Primera Línea,Colorectal Neoplasms
PROVIDER: 2101702 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA